Biotron's most advanced projects are aimed at the development of antiviral therapeutics and cancer diagnostics. The company also has a number of Tier 2 research programs underway, targeting other indications including cardiovascular disease.

• Virion - A Novel Approach to Viral Treatment
• C-Test - A Glycomics Approach to Cancer Diagnostics
• Tier 2 Projects

Biotron's Drug Development Pathway. In its Virion program, Biotron has selected a lead compound for progression into clinical trials.